The proposed agreement, filed in the United States District Court for the Southern District of New York, names Co-Diagnostics, Inc. along with executives Dwight H. Egan and Brian L. Brown as defendants. Lead plaintiff Stadium Capital LLC initiated the action, and the court has now scheduled a fairness hearing for December 8, 2026, before Judge Arun Subramanian to determine if the terms are adequate and should be finalized.
Co-Diagnostics Reaches $6.5 Million Settlement in Class Action Suit
A $6.5 million settlement has been reached in a class action lawsuit involving Co-Diagnostics, Inc., potentially resolving claims brought by investors who purchased the company’s common stock or options between May 12, 2022, and August 11, 2022, following allegations of financial damages during that period.
Class members who wish to participate in the distribution of the settlement fund must submit a valid claim form by January 6, 2027. Alternatively, those who prefer to pursue independent legal action must file a formal request for exclusion by November 17, 2026. Detailed instructions and documentation are available through the court-appointed administrator, RG/2 Claims Administration LLC, or via the dedicated case website.
Comments (0)
No comments yet. Be the first!